Guanhao Biotech
Guangzhou
About Guanhao Biotech
Grandhope Biotech Co., Ltd, a bio-tech company, develops, manufactures, and markets regenerative medical devices for the treatment of damaged tissue and organs in China. The company offers GrandNeuro membrane, an artificial dura patch for dura repairing; and NormalGEN, a type of biological dura repair patch manufactured from animal tissue used for the closure of dura mater during neurosurgery. It also provides ThormalGEN, a biological surgical patch manufactured from animal tissue for surgical repairs; and DermalGEN, a wound dressing product for use on burns, scalds, and wounds due to skin loss or trauma.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 251 – 500
- Estimated revenue: $50K – $100K
- Funding stage: IPO
- Last round: Series Unknown (Jun 2006)
- Ticker: szse:300238
- Website: grandhopebio.com
- Phone: 86 20 3205 2806
Industries & Categories
Biotechnology, Manufacturing
Social Profiles
Canonical: https://fsome.com/organization/guanhao-biotech-317365 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.